Orphazyme's Seed VC - II Round

Orphazyme raised a round of funding on February 14, 2011.

Orphazyme develops new therapies for the treatment of rare and genetic diseases. The company is founded on the pioneering research from the laboratory of Professor Marja Jaattela, and with the aim of …

Articles about Orphazyme's Seed VC - II Round: